http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021241914-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_843659aad9c4fcabeaa8bd2c0728a181 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 |
| filingDate | 2021-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ef71749098f9abb241a683b977cbd92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11e3ca902f57e7d5066747eaac80320e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f22753ef8cbfe9b7f29430258d9eb0e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e18ba587bafdadc9f0ebcae6b8a2e8d8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52c0ca1fc3bead2f1b3fde8e88cea070 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_857664b5df5ae01e535f6e0c7b027204 |
| publicationDate | 2021-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2021241914-A1 |
| titleOfInvention | Antibacterial substance having lytic activity against actinobacillus pleuropneumoniae and method for producing same |
| abstract | The present invention relates to: a proteinaceous antibacterial substance having lytic activity against Actinobacillus pleuropneumoniae, which infects the respiratory system; and a method for producing same. More specifically, the present invention relates to: a proteinaceous antibacterial substance specific to Actinobacillus pleuropneumoniae, the proteinaceous antibacterial substance exhibiting an ability that can specifically lyse Actinobacillus pleuropneumoniae, which infects the porcine respiratory system to cause pleuropneumonia in lung tissue, and being derived from a nucleic acid sequence represented by SEQ ID NO: 1; a strain which produces the proteinaceous antibacterial substance and has genetic material encoding the proteinaceous antibacterial substance; a method for producing the proteinaceous antibacterial substance by using the strain; and a pharmaceutical composition for treating respiratory infections and respiratory diseases caused by Actinobacillus pleuropneumoniae, the pharmaceutical composition containing the proteinaceous antibacterial substance as an active ingredient. |
| priorityDate | 2020-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.